Medtronic appoints Dr. Kweli Thompson as new President of Neuroscience Portfolio, effective June 1, 2026.

{
  "signal_id": "b62ada8b-707c-4640-a6f3-4b99f349b951",
  "signal_type": "sec-8k",
  "signal_subtype": "governanceChange",
  "detected_at": "2026-05-19T10:14:18.793+00:00",
  "company": {
    "name": "Medtronic",
    "domain": "medtronic.com"
  },
  "data": {
    "detail": "A new leader for the major Neuroscience division creates a 90-day window of opportunity for vendor review and strategic shifts. Dr. Thompson will likely re-evaluate current projects, budgets, and technology partners as he takes over from the departing Brett Wall, who will transition out by September 1, 2026.",
    "metrics": {
      "timeframe": "immediate"
    },
    "summary": "Medtronic appoints Dr. Kweli Thompson as new President of Neuroscience Portfolio, effective June 1, 2026.",
    "excerpts": "On May 18, 2026, Medtronic plc (“Medtronic” or the “Company”) announced that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1613103/000162828026035959/mdt-20260518.htm",
    "filing_date": "2026-05-18",
    "filing_year": 2026,
    "fiscal_year_end": "05/18",
    "sales_relevance": "Governance tools needed",
    "signal_category": "esg"
  }
}

curl https://signals.autobound.ai/v1/signals/b62ada8b-707c-4640-a6f3-4b99f349b951 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"medtronic.com","limit":20}'